An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis [IPF] and progressive pulmonary fibrosis [PPF] [FIBRONEER™-ON] (NCT06238622)
FIBRONEER™-ON
This trial is No longer recruiting
Registration number NCT06238622
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
A/Prof Ian Glaspole
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR